Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Q1 2025 Trading Update

20 Nov 2024 07:00

RNS Number : 8631M
Softcat PLC
20 November 2024
 

20 November 2024

 

Softcat plc

 

Q1 2025 Trading Update

 

Softcat plc ("Softcat", or the "Group"), a leading UK provider of IT infrastructure technology and services, today publishes its trading update for the first quarter ended 31 October 2024 ("the Period").

 

The Group performed well during the Period, delivering further growth in gross profit and operating profit. Customer demand remains resilient, supported by our broad portfolio offering and well-diversified customer base. The Board is pleased with progress to date, which is consistent with the outlook provided in our full year results announcement, for double-digit gross profit growth together with high single-digit operating profit growth in FY2025.

 

Graham Charlton, Chief Executive Officer, commented:

 

"I'm pleased to report another positive performance in the Period. As expected in the year to date, customer demand trends have remained largely consistent with those seen in the prior financial year. The breadth and depth of our offering, together with our wealth of expertise, is proving invaluable to customers in an increasingly complex IT landscape. I'm confident that our unique culture and capabilities will enable us to continue building on the current momentum in the business and successfully execute on the significant opportunity we see across our markets."

 

 

 

For further information, please contact:

 

 

 

Softcat plc

Graham Charlton, Chief Executive Officer

+ 44 (0)1628 403 610

Katy Mecklenburgh, Chief Financial Officer

Michael Watts, Head of Investor Relations

Media Enquiries ‐ FTI Consulting LLP

 

Ed Bridges/Matt Dixon

+ 44 (0)20 3727 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFMFWUELSEDF
Date   Source Headline
2nd Jan 20249:50 amRNSTotal Voting Rights
18th Dec 20239:58 amRNSBlock listing Interim Review
14th Dec 202311:29 amRNSDirector/PDMR Shareholding
14th Dec 202311:25 amRNSResult of AGM
12th Dec 20234:20 pmRNSDirector/PDMR Shareholding
8th Dec 20231:02 pmRNSDirector/PDMR Shareholding
1st Dec 20233:58 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSQ1 2024 Trading Update
24th Nov 20234:54 pmRNSDirector/PDMR Shareholding
24th Nov 20234:51 pmRNSDirector/PDMR Shareholding
8th Nov 20233:22 pmRNSDirector/PDMR Shareholding
1st Nov 202310:08 amRNSAnnual Financial Report and Notice of AGM
24th Oct 20237:00 amRNSFinal Results
10th Oct 202310:40 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSNotice of Results
2nd Oct 202310:38 amRNSTotal Voting Rights
8th Sep 20232:32 pmRNSDirector/PDMR Shareholding
1st Sep 202310:04 amRNSTotal Voting Rights
10th Aug 202310:59 amRNSDirector/PDMR Shareholding
1st Aug 202312:22 pmRNSTotal Voting Rights
1st Aug 20237:00 amRNSAppointment of Non-Executive Directors
10th Jul 20232:10 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:19 amRNSTotal Voting Rights
8th Jun 202311:23 amRNSDirector/PDMR Shareholding
1st Jun 202312:32 pmRNSTotal Voting Rights
1st Jun 202311:08 amRNSBlock listing Interim Review
30th May 20237:00 amRNSQ3 2023 Trading Update
25th May 20238:47 amRNSDirector Declaration
10th May 20238:59 amRNSDirector/PDMR Shareholding
2nd May 20235:08 pmRNSTotal Voting Rights
12th Apr 202310:14 amRNSDirector/PDMR Shareholding
3rd Apr 20239:34 amRNSTotal Voting Rights
28th Mar 20237:00 amRNSHalf-year Report
16th Mar 20232:39 pmRNSConfirmation of CFO Appointment Date
15th Mar 20237:00 amRNSNotice of Results
9th Mar 20232:27 pmRNSDirector/PDMR Shareholding
1st Mar 202312:27 pmRNSTotal Voting Rights
8th Feb 20231:05 pmRNSDirector/PDMR Shareholding
1st Feb 202312:41 pmRNSTotal Voting Rights
17th Jan 20237:05 amRNSDirectorate Change
10th Jan 20232:23 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:34 amRNSTotal Voting Rights
3rd Jan 202311:31 amRNSDirector/PDMR Shareholding
22nd Dec 20223:00 pmRNSDirector/PDMR Shareholding
14th Dec 202210:12 amRNSResult of AGM
8th Dec 202212:29 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:57 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:54 pmRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSChief Financial Officer Appointment
1st Dec 202211:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.